FDA warning: New batch of fake bevacizumab found

摘要

A COUNTERFEIT VERSION OF THE injectable cancer drug bevaci-zumab that may contain no active ingredient has been distributed to clinics in the United States, according to a US Food and Drug Administration (FDA) alert to physicians. The incident is the latest in a string of cases in which foreign drug distributors have sold counterfeit medications to US medical practices.According to the warning (http: //tinyurl.com/ael9nwu), a US com-?. pany calling itself Medical Device King (also known as Pharmalogical) distributed 2 batches of a counterfeit version of bevacizumab labeled as Altuzan. The counterfeits were labeled as Altuzan